Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2000
Calcitonin gene-related peptide decreases expression of HLA-DR and CD86 by human dendritic cells and dampens dendritic cell-driven T cell-proliferative responses via the type I calcitonin gene-related peptide receptorJ A Carucci, R Ignatius, Y Wei, et al.
International Journal of Cardiology|January 31, 2021
Application of the heart failure meta-score to predict prognosis in patients with cardiac resynchronization defibrillatorsDominic A M J Theuns, Beat A Schaer, Kadir Caliskan, et al.
European Journal of Heart Failure|October 7, 2010
Close connection between improvement in left ventricular function by cardiac resynchronization therapy and the incidence of arrhythmias in cardiac resynchronization therapy-defibrillator patientsBeat A Schaer, Stefan Osswald, Marcello Di Valentino, et al.
The American Journal of Cardiology|April 21, 2012
Performance of the Seattle Heart Failure Model in implantable defibrillator patients treated with cardiac resynchronization therapyTim Smith, Wayne C Levy, Beat A Schaer, et al.
Swiss Medical Weekly|September 20, 2006
Early clinical experience with CardioCard - a credit card-sized electronic patient recordAlain M Bernheim, Beat A Schaer, Christoph Kaufmann, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 27, 2015
Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over timeSimon von Gunten, Beat A Schaer, Sing-Chien Yap, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|September 14, 2010
The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortalityDominic A M J Theuns, Beat A Schaer, Osama I I Soliman, et al.
Journal of Proteome Research|January 9, 2015
Integrative proteome and transcriptome analysis of extramedullary erythropoiesis and its reversal by transferrin treatment in a mouse model of beta-thalassemiaFlorence Vallelian, Monique P Gelderman-Fuhrmann, Christian A Schaer, et al.
Cell Death and Differentiation|September 3, 2013
Mechanisms of haptoglobin protection against hemoglobin peroxidation triggered endothelial damageC A Schaer, J W Deuel, A G Bittermann, et al.
Intensive Care Medicine Experimental|August 22, 2018
Heart rate elevations during early sepsis predict death in fluid-resuscitated rats with fecal peritonitisAlain Rudiger, Victor Jeger, Mattia Arrigo, et al.
Pageof 8